nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Trimethadione—epilepsy syndrome	0.0463	0.067	CbGbCtD
Metronidazole—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0435	0.063	CbGbCtD
Metronidazole—CYP2C9—Trimethadione—epilepsy syndrome	0.0323	0.0467	CbGbCtD
Metronidazole—CYP2C8—Carbamazepine—epilepsy syndrome	0.0313	0.0452	CbGbCtD
Metronidazole—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0304	0.0439	CbGbCtD
Metronidazole—CYP2C8—Primidone—epilepsy syndrome	0.0292	0.0422	CbGbCtD
Metronidazole—CYP2C8—Phenytoin—epilepsy syndrome	0.0281	0.0406	CbGbCtD
Metronidazole—CYP2C8—Propofol—epilepsy syndrome	0.0262	0.0378	CbGbCtD
Metronidazole—CYP2C8—Phenobarbital—epilepsy syndrome	0.025	0.0362	CbGbCtD
Metronidazole—CYP2C8—Diazepam—epilepsy syndrome	0.0237	0.0343	CbGbCtD
Metronidazole—CYP2C9—Carbamazepine—epilepsy syndrome	0.0218	0.0316	CbGbCtD
Metronidazole—CYP2C9—Primidone—epilepsy syndrome	0.0204	0.0295	CbGbCtD
Metronidazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0202	0.0292	CbGbCtD
Metronidazole—CYP2C9—Phenytoin—epilepsy syndrome	0.0196	0.0283	CbGbCtD
Metronidazole—CYP3A4—Felbamate—epilepsy syndrome	0.0188	0.0272	CbGbCtD
Metronidazole—CYP3A4—Trimethadione—epilepsy syndrome	0.0188	0.0272	CbGbCtD
Metronidazole—CYP2C8—Valproic Acid—epilepsy syndrome	0.0187	0.027	CbGbCtD
Metronidazole—CYP2C9—Propofol—epilepsy syndrome	0.0183	0.0264	CbGbCtD
Metronidazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0177	0.0255	CbGbCtD
Metronidazole—CYP2C9—Phenobarbital—epilepsy syndrome	0.0174	0.0252	CbGbCtD
Metronidazole—CYP2C9—Diazepam—epilepsy syndrome	0.0165	0.0239	CbGbCtD
Metronidazole—CYP3A4—Clonazepam—epilepsy syndrome	0.016	0.0231	CbGbCtD
Metronidazole—CYP3A4—Clobazam—epilepsy syndrome	0.0153	0.0221	CbGbCtD
Metronidazole—CYP2C9—Valproic Acid—epilepsy syndrome	0.013	0.0188	CbGbCtD
Metronidazole—CYP3A4—Rufinamide—epilepsy syndrome	0.013	0.0188	CbGbCtD
Metronidazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.0127	0.0183	CbGbCtD
Metronidazole—CYP3A4—Primidone—epilepsy syndrome	0.0118	0.0171	CbGbCtD
Metronidazole—CYP3A4—Phenytoin—epilepsy syndrome	0.0114	0.0165	CbGbCtD
Metronidazole—CYP3A4—Propofol—epilepsy syndrome	0.0106	0.0153	CbGbCtD
Metronidazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.0101	0.0147	CbGbCtD
Metronidazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.0101	0.0147	CbGbCtD
Metronidazole—CYP3A4—Midazolam—epilepsy syndrome	0.01	0.0145	CbGbCtD
Metronidazole—CYP3A4—Diazepam—epilepsy syndrome	0.00961	0.0139	CbGbCtD
Metronidazole—CYP3A4—Zonisamide—epilepsy syndrome	0.00938	0.0136	CbGbCtD
Metronidazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.00758	0.011	CbGbCtD
Metronidazole—CYP3A4—Topiramate—epilepsy syndrome	0.00684	0.00989	CbGbCtD
Metronidazole—Pruritus—Clonazepam—epilepsy syndrome	5.37e-05	0.00018	CcSEcCtD
Metronidazole—Vomiting—Vigabatrin—epilepsy syndrome	5.37e-05	0.000179	CcSEcCtD
Metronidazole—Skin disorder—Valproic Acid—epilepsy syndrome	5.37e-05	0.000179	CcSEcCtD
Metronidazole—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.35e-05	0.000179	CcSEcCtD
Metronidazole—Pruritus—Phenytoin—epilepsy syndrome	5.34e-05	0.000178	CcSEcCtD
Metronidazole—Connective tissue disorder—Topiramate—epilepsy syndrome	5.34e-05	0.000178	CcSEcCtD
Metronidazole—Nausea—Levetiracetam—epilepsy syndrome	5.34e-05	0.000178	CcSEcCtD
Metronidazole—Rash—Vigabatrin—epilepsy syndrome	5.33e-05	0.000178	CcSEcCtD
Metronidazole—Dizziness—Felbamate—epilepsy syndrome	5.33e-05	0.000178	CcSEcCtD
Metronidazole—Dermatitis—Vigabatrin—epilepsy syndrome	5.32e-05	0.000178	CcSEcCtD
Metronidazole—Pruritus—Oxcarbazepine—epilepsy syndrome	5.31e-05	0.000177	CcSEcCtD
Metronidazole—Convulsion—Pregabalin—epilepsy syndrome	5.31e-05	0.000177	CcSEcCtD
Metronidazole—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.31e-05	0.000177	CcSEcCtD
Metronidazole—Vision blurred—Gabapentin—epilepsy syndrome	5.3e-05	0.000177	CcSEcCtD
Metronidazole—Headache—Vigabatrin—epilepsy syndrome	5.29e-05	0.000177	CcSEcCtD
Metronidazole—Hypertension—Pregabalin—epilepsy syndrome	5.29e-05	0.000177	CcSEcCtD
Metronidazole—Vomiting—Diazepam—epilepsy syndrome	5.29e-05	0.000177	CcSEcCtD
Metronidazole—Anorexia—Valproic Acid—epilepsy syndrome	5.27e-05	0.000176	CcSEcCtD
Metronidazole—Tremor—Gabapentin—epilepsy syndrome	5.26e-05	0.000176	CcSEcCtD
Metronidazole—Rash—Diazepam—epilepsy syndrome	5.25e-05	0.000175	CcSEcCtD
Metronidazole—Dermatitis—Diazepam—epilepsy syndrome	5.24e-05	0.000175	CcSEcCtD
Metronidazole—Visual impairment—Topiramate—epilepsy syndrome	5.23e-05	0.000175	CcSEcCtD
Metronidazole—Arthralgia—Pregabalin—epilepsy syndrome	5.22e-05	0.000174	CcSEcCtD
Metronidazole—Chest pain—Pregabalin—epilepsy syndrome	5.22e-05	0.000174	CcSEcCtD
Metronidazole—Dizziness—Zonisamide—epilepsy syndrome	5.21e-05	0.000174	CcSEcCtD
Metronidazole—Headache—Diazepam—epilepsy syndrome	5.21e-05	0.000174	CcSEcCtD
Metronidazole—Diarrhoea—Clonazepam—epilepsy syndrome	5.2e-05	0.000174	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.18e-05	0.000173	CcSEcCtD
Metronidazole—Asthenia—Carbamazepine—epilepsy syndrome	5.17e-05	0.000173	CcSEcCtD
Metronidazole—Diarrhoea—Phenytoin—epilepsy syndrome	5.16e-05	0.000172	CcSEcCtD
Metronidazole—Nausea—Fosphenytoin—epilepsy syndrome	5.15e-05	0.000172	CcSEcCtD
Metronidazole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.14e-05	0.000172	CcSEcCtD
Metronidazole—Erythema multiforme—Topiramate—epilepsy syndrome	5.13e-05	0.000171	CcSEcCtD
Metronidazole—Angioedema—Gabapentin—epilepsy syndrome	5.13e-05	0.000171	CcSEcCtD
Metronidazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.13e-05	0.000171	CcSEcCtD
Metronidazole—Vomiting—Felbamate—epilepsy syndrome	5.12e-05	0.000171	CcSEcCtD
Metronidazole—Dry mouth—Pregabalin—epilepsy syndrome	5.1e-05	0.00017	CcSEcCtD
Metronidazole—Pruritus—Carbamazepine—epilepsy syndrome	5.1e-05	0.00017	CcSEcCtD
Metronidazole—Rash—Felbamate—epilepsy syndrome	5.08e-05	0.00017	CcSEcCtD
Metronidazole—Eye disorder—Topiramate—epilepsy syndrome	5.07e-05	0.00017	CcSEcCtD
Metronidazole—Dermatitis—Felbamate—epilepsy syndrome	5.07e-05	0.000169	CcSEcCtD
Metronidazole—Malaise—Gabapentin—epilepsy syndrome	5.07e-05	0.000169	CcSEcCtD
Metronidazole—Tinnitus—Topiramate—epilepsy syndrome	5.06e-05	0.000169	CcSEcCtD
Metronidazole—Vertigo—Gabapentin—epilepsy syndrome	5.05e-05	0.000169	CcSEcCtD
Metronidazole—Headache—Felbamate—epilepsy syndrome	5.04e-05	0.000168	CcSEcCtD
Metronidazole—Confusional state—Pregabalin—epilepsy syndrome	5.04e-05	0.000168	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.04e-05	0.000168	CcSEcCtD
Metronidazole—Flushing—Topiramate—epilepsy syndrome	5.04e-05	0.000168	CcSEcCtD
Metronidazole—Cardiac disorder—Topiramate—epilepsy syndrome	5.04e-05	0.000168	CcSEcCtD
Metronidazole—Syncope—Gabapentin—epilepsy syndrome	5.04e-05	0.000168	CcSEcCtD
Metronidazole—Leukopenia—Gabapentin—epilepsy syndrome	5.03e-05	0.000168	CcSEcCtD
Metronidazole—Dizziness—Clonazepam—epilepsy syndrome	5.02e-05	0.000168	CcSEcCtD
Metronidazole—Nausea—Vigabatrin—epilepsy syndrome	5.02e-05	0.000168	CcSEcCtD
Metronidazole—Vomiting—Zonisamide—epilepsy syndrome	5.01e-05	0.000167	CcSEcCtD
Metronidazole—Insomnia—Valproic Acid—epilepsy syndrome	5e-05	0.000167	CcSEcCtD
Metronidazole—Anaphylactic shock—Pregabalin—epilepsy syndrome	5e-05	0.000167	CcSEcCtD
Metronidazole—Oedema—Pregabalin—epilepsy syndrome	5e-05	0.000167	CcSEcCtD
Metronidazole—Asthenia—Lamotrigine—epilepsy syndrome	4.99e-05	0.000167	CcSEcCtD
Metronidazole—Dizziness—Phenytoin—epilepsy syndrome	4.99e-05	0.000167	CcSEcCtD
Metronidazole—Rash—Zonisamide—epilepsy syndrome	4.97e-05	0.000166	CcSEcCtD
Metronidazole—Infection—Pregabalin—epilepsy syndrome	4.97e-05	0.000166	CcSEcCtD
Metronidazole—Paraesthesia—Valproic Acid—epilepsy syndrome	4.97e-05	0.000166	CcSEcCtD
Metronidazole—Palpitations—Gabapentin—epilepsy syndrome	4.97e-05	0.000166	CcSEcCtD
Metronidazole—Dermatitis—Zonisamide—epilepsy syndrome	4.97e-05	0.000166	CcSEcCtD
Metronidazole—Dizziness—Oxcarbazepine—epilepsy syndrome	4.96e-05	0.000166	CcSEcCtD
Metronidazole—Nausea—Diazepam—epilepsy syndrome	4.94e-05	0.000165	CcSEcCtD
Metronidazole—Loss of consciousness—Gabapentin—epilepsy syndrome	4.94e-05	0.000165	CcSEcCtD
Metronidazole—Headache—Zonisamide—epilepsy syndrome	4.94e-05	0.000165	CcSEcCtD
Metronidazole—Diarrhoea—Carbamazepine—epilepsy syndrome	4.93e-05	0.000165	CcSEcCtD
Metronidazole—Angiopathy—Topiramate—epilepsy syndrome	4.93e-05	0.000165	CcSEcCtD
Metronidazole—Pruritus—Lamotrigine—epilepsy syndrome	4.93e-05	0.000165	CcSEcCtD
Metronidazole—Shock—Pregabalin—epilepsy syndrome	4.92e-05	0.000164	CcSEcCtD
Metronidazole—Somnolence—Valproic Acid—epilepsy syndrome	4.92e-05	0.000164	CcSEcCtD
Metronidazole—Immune system disorder—Topiramate—epilepsy syndrome	4.9e-05	0.000164	CcSEcCtD
Metronidazole—Nervous system disorder—Pregabalin—epilepsy syndrome	4.9e-05	0.000164	CcSEcCtD
Metronidazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.9e-05	0.000164	CcSEcCtD
Metronidazole—Mediastinal disorder—Topiramate—epilepsy syndrome	4.89e-05	0.000163	CcSEcCtD
Metronidazole—Dyspepsia—Valproic Acid—epilepsy syndrome	4.87e-05	0.000163	CcSEcCtD
Metronidazole—Convulsion—Gabapentin—epilepsy syndrome	4.87e-05	0.000163	CcSEcCtD
Metronidazole—Skin disorder—Pregabalin—epilepsy syndrome	4.86e-05	0.000162	CcSEcCtD
Metronidazole—Hypertension—Gabapentin—epilepsy syndrome	4.85e-05	0.000162	CcSEcCtD
Metronidazole—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.83e-05	0.000161	CcSEcCtD
Metronidazole—Vomiting—Clonazepam—epilepsy syndrome	4.83e-05	0.000161	CcSEcCtD
Metronidazole—Decreased appetite—Valproic Acid—epilepsy syndrome	4.81e-05	0.000161	CcSEcCtD
Metronidazole—Vomiting—Phenytoin—epilepsy syndrome	4.8e-05	0.00016	CcSEcCtD
Metronidazole—Rash—Clonazepam—epilepsy syndrome	4.79e-05	0.00016	CcSEcCtD
Metronidazole—Dermatitis—Clonazepam—epilepsy syndrome	4.79e-05	0.00016	CcSEcCtD
Metronidazole—Arthralgia—Gabapentin—epilepsy syndrome	4.78e-05	0.00016	CcSEcCtD
Metronidazole—Chest pain—Gabapentin—epilepsy syndrome	4.78e-05	0.00016	CcSEcCtD
Metronidazole—Nausea—Felbamate—epilepsy syndrome	4.78e-05	0.00016	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.78e-05	0.00016	CcSEcCtD
Metronidazole—Vomiting—Oxcarbazepine—epilepsy syndrome	4.77e-05	0.000159	CcSEcCtD
Metronidazole—Fatigue—Valproic Acid—epilepsy syndrome	4.77e-05	0.000159	CcSEcCtD
Metronidazole—Anorexia—Pregabalin—epilepsy syndrome	4.77e-05	0.000159	CcSEcCtD
Metronidazole—Dizziness—Carbamazepine—epilepsy syndrome	4.76e-05	0.000159	CcSEcCtD
Metronidazole—Diarrhoea—Lamotrigine—epilepsy syndrome	4.76e-05	0.000159	CcSEcCtD
Metronidazole—Headache—Clonazepam—epilepsy syndrome	4.76e-05	0.000159	CcSEcCtD
Metronidazole—Rash—Phenytoin—epilepsy syndrome	4.76e-05	0.000159	CcSEcCtD
Metronidazole—Mental disorder—Topiramate—epilepsy syndrome	4.76e-05	0.000159	CcSEcCtD
Metronidazole—Dermatitis—Phenytoin—epilepsy syndrome	4.75e-05	0.000159	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.75e-05	0.000159	CcSEcCtD
Metronidazole—Rash—Oxcarbazepine—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Metronidazole—Constipation—Valproic Acid—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Metronidazole—Pain—Valproic Acid—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Metronidazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Metronidazole—Headache—Phenytoin—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Metronidazole—Erythema—Topiramate—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Metronidazole—Headache—Oxcarbazepine—epilepsy syndrome	4.7e-05	0.000157	CcSEcCtD
Metronidazole—Nausea—Zonisamide—epilepsy syndrome	4.68e-05	0.000156	CcSEcCtD
Metronidazole—Dry mouth—Gabapentin—epilepsy syndrome	4.68e-05	0.000156	CcSEcCtD
Metronidazole—Flatulence—Topiramate—epilepsy syndrome	4.66e-05	0.000156	CcSEcCtD
Metronidazole—Dysgeusia—Topiramate—epilepsy syndrome	4.63e-05	0.000155	CcSEcCtD
Metronidazole—Confusional state—Gabapentin—epilepsy syndrome	4.62e-05	0.000154	CcSEcCtD
Metronidazole—Dizziness—Lamotrigine—epilepsy syndrome	4.6e-05	0.000154	CcSEcCtD
Metronidazole—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.59e-05	0.000153	CcSEcCtD
Metronidazole—Oedema—Gabapentin—epilepsy syndrome	4.59e-05	0.000153	CcSEcCtD
Metronidazole—Vomiting—Carbamazepine—epilepsy syndrome	4.58e-05	0.000153	CcSEcCtD
Metronidazole—Back pain—Topiramate—epilepsy syndrome	4.57e-05	0.000153	CcSEcCtD
Metronidazole—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.56e-05	0.000152	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.56e-05	0.000152	CcSEcCtD
Metronidazole—Infection—Gabapentin—epilepsy syndrome	4.56e-05	0.000152	CcSEcCtD
Metronidazole—Muscle spasms—Topiramate—epilepsy syndrome	4.54e-05	0.000152	CcSEcCtD
Metronidazole—Rash—Carbamazepine—epilepsy syndrome	4.54e-05	0.000152	CcSEcCtD
Metronidazole—Dermatitis—Carbamazepine—epilepsy syndrome	4.54e-05	0.000152	CcSEcCtD
Metronidazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.52e-05	0.000151	CcSEcCtD
Metronidazole—Insomnia—Pregabalin—epilepsy syndrome	4.52e-05	0.000151	CcSEcCtD
Metronidazole—Nausea—Clonazepam—epilepsy syndrome	4.51e-05	0.000151	CcSEcCtD
Metronidazole—Headache—Carbamazepine—epilepsy syndrome	4.51e-05	0.000151	CcSEcCtD
Metronidazole—Shock—Gabapentin—epilepsy syndrome	4.51e-05	0.000151	CcSEcCtD
Metronidazole—Nervous system disorder—Gabapentin—epilepsy syndrome	4.5e-05	0.00015	CcSEcCtD
Metronidazole—Paraesthesia—Pregabalin—epilepsy syndrome	4.49e-05	0.00015	CcSEcCtD
Metronidazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.49e-05	0.00015	CcSEcCtD
Metronidazole—Nausea—Phenytoin—epilepsy syndrome	4.48e-05	0.00015	CcSEcCtD
Metronidazole—Nausea—Oxcarbazepine—epilepsy syndrome	4.46e-05	0.000149	CcSEcCtD
Metronidazole—Vision blurred—Topiramate—epilepsy syndrome	4.46e-05	0.000149	CcSEcCtD
Metronidazole—Skin disorder—Gabapentin—epilepsy syndrome	4.45e-05	0.000149	CcSEcCtD
Metronidazole—Somnolence—Pregabalin—epilepsy syndrome	4.45e-05	0.000148	CcSEcCtD
Metronidazole—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.43e-05	0.000148	CcSEcCtD
Metronidazole—Tremor—Topiramate—epilepsy syndrome	4.43e-05	0.000148	CcSEcCtD
Metronidazole—Vomiting—Lamotrigine—epilepsy syndrome	4.43e-05	0.000148	CcSEcCtD
Metronidazole—Urticaria—Valproic Acid—epilepsy syndrome	4.39e-05	0.000147	CcSEcCtD
Metronidazole—Rash—Lamotrigine—epilepsy syndrome	4.39e-05	0.000147	CcSEcCtD
Metronidazole—Dermatitis—Lamotrigine—epilepsy syndrome	4.39e-05	0.000146	CcSEcCtD
Metronidazole—Abdominal pain—Valproic Acid—epilepsy syndrome	4.37e-05	0.000146	CcSEcCtD
Metronidazole—Body temperature increased—Valproic Acid—epilepsy syndrome	4.37e-05	0.000146	CcSEcCtD
Metronidazole—Anorexia—Gabapentin—epilepsy syndrome	4.37e-05	0.000146	CcSEcCtD
Metronidazole—Headache—Lamotrigine—epilepsy syndrome	4.36e-05	0.000146	CcSEcCtD
Metronidazole—Decreased appetite—Pregabalin—epilepsy syndrome	4.35e-05	0.000145	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.32e-05	0.000144	CcSEcCtD
Metronidazole—Fatigue—Pregabalin—epilepsy syndrome	4.31e-05	0.000144	CcSEcCtD
Metronidazole—Nausea—Carbamazepine—epilepsy syndrome	4.28e-05	0.000143	CcSEcCtD
Metronidazole—Pain—Pregabalin—epilepsy syndrome	4.28e-05	0.000143	CcSEcCtD
Metronidazole—Constipation—Pregabalin—epilepsy syndrome	4.28e-05	0.000143	CcSEcCtD
Metronidazole—Malaise—Topiramate—epilepsy syndrome	4.26e-05	0.000142	CcSEcCtD
Metronidazole—Vertigo—Topiramate—epilepsy syndrome	4.25e-05	0.000142	CcSEcCtD
Metronidazole—Syncope—Topiramate—epilepsy syndrome	4.24e-05	0.000142	CcSEcCtD
Metronidazole—Leukopenia—Topiramate—epilepsy syndrome	4.23e-05	0.000141	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.18e-05	0.00014	CcSEcCtD
Metronidazole—Palpitations—Topiramate—epilepsy syndrome	4.18e-05	0.00014	CcSEcCtD
Metronidazole—Loss of consciousness—Topiramate—epilepsy syndrome	4.15e-05	0.000139	CcSEcCtD
Metronidazole—Insomnia—Gabapentin—epilepsy syndrome	4.15e-05	0.000139	CcSEcCtD
Metronidazole—Nausea—Lamotrigine—epilepsy syndrome	4.13e-05	0.000138	CcSEcCtD
Metronidazole—Feeling abnormal—Pregabalin—epilepsy syndrome	4.12e-05	0.000138	CcSEcCtD
Metronidazole—Paraesthesia—Gabapentin—epilepsy syndrome	4.12e-05	0.000138	CcSEcCtD
Metronidazole—Convulsion—Topiramate—epilepsy syndrome	4.1e-05	0.000137	CcSEcCtD
Metronidazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.09e-05	0.000137	CcSEcCtD
Metronidazole—Hypertension—Topiramate—epilepsy syndrome	4.08e-05	0.000136	CcSEcCtD
Metronidazole—Somnolence—Gabapentin—epilepsy syndrome	4.08e-05	0.000136	CcSEcCtD
Metronidazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.08e-05	0.000136	CcSEcCtD
Metronidazole—Dyspepsia—Gabapentin—epilepsy syndrome	4.04e-05	0.000135	CcSEcCtD
Metronidazole—Chest pain—Topiramate—epilepsy syndrome	4.02e-05	0.000134	CcSEcCtD
Metronidazole—Arthralgia—Topiramate—epilepsy syndrome	4.02e-05	0.000134	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4e-05	0.000133	CcSEcCtD
Metronidazole—Decreased appetite—Gabapentin—epilepsy syndrome	3.99e-05	0.000133	CcSEcCtD
Metronidazole—Urticaria—Pregabalin—epilepsy syndrome	3.97e-05	0.000133	CcSEcCtD
Metronidazole—Asthenia—Valproic Acid—epilepsy syndrome	3.97e-05	0.000133	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.96e-05	0.000132	CcSEcCtD
Metronidazole—Fatigue—Gabapentin—epilepsy syndrome	3.95e-05	0.000132	CcSEcCtD
Metronidazole—Abdominal pain—Pregabalin—epilepsy syndrome	3.95e-05	0.000132	CcSEcCtD
Metronidazole—Body temperature increased—Pregabalin—epilepsy syndrome	3.95e-05	0.000132	CcSEcCtD
Metronidazole—Dry mouth—Topiramate—epilepsy syndrome	3.94e-05	0.000131	CcSEcCtD
Metronidazole—Pain—Gabapentin—epilepsy syndrome	3.92e-05	0.000131	CcSEcCtD
Metronidazole—Constipation—Gabapentin—epilepsy syndrome	3.92e-05	0.000131	CcSEcCtD
Metronidazole—Pruritus—Valproic Acid—epilepsy syndrome	3.91e-05	0.000131	CcSEcCtD
Metronidazole—Confusional state—Topiramate—epilepsy syndrome	3.89e-05	0.00013	CcSEcCtD
Metronidazole—Oedema—Topiramate—epilepsy syndrome	3.86e-05	0.000129	CcSEcCtD
Metronidazole—Infection—Topiramate—epilepsy syndrome	3.83e-05	0.000128	CcSEcCtD
Metronidazole—Shock—Topiramate—epilepsy syndrome	3.8e-05	0.000127	CcSEcCtD
Metronidazole—Diarrhoea—Valproic Acid—epilepsy syndrome	3.78e-05	0.000126	CcSEcCtD
Metronidazole—Nervous system disorder—Topiramate—epilepsy syndrome	3.78e-05	0.000126	CcSEcCtD
Metronidazole—Feeling abnormal—Gabapentin—epilepsy syndrome	3.78e-05	0.000126	CcSEcCtD
Metronidazole—Thrombocytopenia—Topiramate—epilepsy syndrome	3.78e-05	0.000126	CcSEcCtD
Metronidazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.75e-05	0.000125	CcSEcCtD
Metronidazole—Skin disorder—Topiramate—epilepsy syndrome	3.75e-05	0.000125	CcSEcCtD
Metronidazole—Hyperhidrosis—Topiramate—epilepsy syndrome	3.73e-05	0.000125	CcSEcCtD
Metronidazole—Hypersensitivity—Pregabalin—epilepsy syndrome	3.68e-05	0.000123	CcSEcCtD
Metronidazole—Anorexia—Topiramate—epilepsy syndrome	3.68e-05	0.000123	CcSEcCtD
Metronidazole—Dizziness—Valproic Acid—epilepsy syndrome	3.66e-05	0.000122	CcSEcCtD
Metronidazole—Urticaria—Gabapentin—epilepsy syndrome	3.64e-05	0.000122	CcSEcCtD
Metronidazole—Body temperature increased—Gabapentin—epilepsy syndrome	3.63e-05	0.000121	CcSEcCtD
Metronidazole—Abdominal pain—Gabapentin—epilepsy syndrome	3.63e-05	0.000121	CcSEcCtD
Metronidazole—Asthenia—Pregabalin—epilepsy syndrome	3.59e-05	0.00012	CcSEcCtD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.56e-05	0.00391	CbGpPWpGaD
Metronidazole—Pruritus—Pregabalin—epilepsy syndrome	3.54e-05	0.000118	CcSEcCtD
Metronidazole—Vomiting—Valproic Acid—epilepsy syndrome	3.52e-05	0.000117	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.51e-05	0.000117	CcSEcCtD
Metronidazole—Insomnia—Topiramate—epilepsy syndrome	3.49e-05	0.000117	CcSEcCtD
Metronidazole—Rash—Valproic Acid—epilepsy syndrome	3.49e-05	0.000116	CcSEcCtD
Metronidazole—Dermatitis—Valproic Acid—epilepsy syndrome	3.48e-05	0.000116	CcSEcCtD
Metronidazole—Headache—Valproic Acid—epilepsy syndrome	3.47e-05	0.000116	CcSEcCtD
Metronidazole—Paraesthesia—Topiramate—epilepsy syndrome	3.46e-05	0.000116	CcSEcCtD
Metronidazole—Somnolence—Topiramate—epilepsy syndrome	3.43e-05	0.000115	CcSEcCtD
Metronidazole—Diarrhoea—Pregabalin—epilepsy syndrome	3.42e-05	0.000114	CcSEcCtD
Metronidazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	3.42e-05	0.00376	CbGpPWpGaD
Metronidazole—Dyspepsia—Topiramate—epilepsy syndrome	3.4e-05	0.000113	CcSEcCtD
Metronidazole—Hypersensitivity—Gabapentin—epilepsy syndrome	3.38e-05	0.000113	CcSEcCtD
Metronidazole—CYP2C9—Arachidonic acid metabolism—GPX1—epilepsy syndrome	3.38e-05	0.00371	CbGpPWpGaD
Metronidazole—Decreased appetite—Topiramate—epilepsy syndrome	3.35e-05	0.000112	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.33e-05	0.000111	CcSEcCtD
Metronidazole—Fatigue—Topiramate—epilepsy syndrome	3.33e-05	0.000111	CcSEcCtD
Metronidazole—Dizziness—Pregabalin—epilepsy syndrome	3.31e-05	0.00011	CcSEcCtD
Metronidazole—Pain—Topiramate—epilepsy syndrome	3.3e-05	0.00011	CcSEcCtD
Metronidazole—Constipation—Topiramate—epilepsy syndrome	3.3e-05	0.00011	CcSEcCtD
Metronidazole—Asthenia—Gabapentin—epilepsy syndrome	3.29e-05	0.00011	CcSEcCtD
Metronidazole—Nausea—Valproic Acid—epilepsy syndrome	3.29e-05	0.00011	CcSEcCtD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	3.26e-05	0.00358	CbGpPWpGaD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	3.25e-05	0.00357	CbGpPWpGaD
Metronidazole—Pruritus—Gabapentin—epilepsy syndrome	3.24e-05	0.000108	CcSEcCtD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	3.23e-05	0.00355	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	3.21e-05	0.00353	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	3.19e-05	0.0035	CbGpPWpGaD
Metronidazole—Vomiting—Pregabalin—epilepsy syndrome	3.18e-05	0.000106	CcSEcCtD
Metronidazole—Feeling abnormal—Topiramate—epilepsy syndrome	3.18e-05	0.000106	CcSEcCtD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	3.17e-05	0.00348	CbGpPWpGaD
Metronidazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.15e-05	0.000105	CcSEcCtD
Metronidazole—Rash—Pregabalin—epilepsy syndrome	3.15e-05	0.000105	CcSEcCtD
Metronidazole—Dermatitis—Pregabalin—epilepsy syndrome	3.15e-05	0.000105	CcSEcCtD
Metronidazole—Diarrhoea—Gabapentin—epilepsy syndrome	3.14e-05	0.000105	CcSEcCtD
Metronidazole—Headache—Pregabalin—epilepsy syndrome	3.13e-05	0.000105	CcSEcCtD
Metronidazole—Urticaria—Topiramate—epilepsy syndrome	3.06e-05	0.000102	CcSEcCtD
Metronidazole—Abdominal pain—Topiramate—epilepsy syndrome	3.05e-05	0.000102	CcSEcCtD
Metronidazole—Body temperature increased—Topiramate—epilepsy syndrome	3.05e-05	0.000102	CcSEcCtD
Metronidazole—Dizziness—Gabapentin—epilepsy syndrome	3.03e-05	0.000101	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	3.02e-05	0.00331	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	3.02e-05	0.00331	CbGpPWpGaD
Metronidazole—Nausea—Pregabalin—epilepsy syndrome	2.97e-05	9.92e-05	CcSEcCtD
Metronidazole—Vomiting—Gabapentin—epilepsy syndrome	2.92e-05	9.74e-05	CcSEcCtD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	2.9e-05	0.00318	CbGpPWpGaD
Metronidazole—Rash—Gabapentin—epilepsy syndrome	2.89e-05	9.66e-05	CcSEcCtD
Metronidazole—Dermatitis—Gabapentin—epilepsy syndrome	2.89e-05	9.65e-05	CcSEcCtD
Metronidazole—Headache—Gabapentin—epilepsy syndrome	2.87e-05	9.6e-05	CcSEcCtD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	2.86e-05	0.00314	CbGpPWpGaD
Metronidazole—Hypersensitivity—Topiramate—epilepsy syndrome	2.84e-05	9.49e-05	CcSEcCtD
Metronidazole—Asthenia—Topiramate—epilepsy syndrome	2.77e-05	9.25e-05	CcSEcCtD
Metronidazole—Pruritus—Topiramate—epilepsy syndrome	2.73e-05	9.12e-05	CcSEcCtD
Metronidazole—Nausea—Gabapentin—epilepsy syndrome	2.72e-05	9.1e-05	CcSEcCtD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.65e-05	0.00291	CbGpPWpGaD
Metronidazole—Diarrhoea—Topiramate—epilepsy syndrome	2.64e-05	8.82e-05	CcSEcCtD
Metronidazole—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	2.63e-05	0.00289	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	2.62e-05	0.00288	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.6e-05	0.00286	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP2C19—epilepsy syndrome	2.59e-05	0.00285	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP11A1—epilepsy syndrome	2.58e-05	0.00283	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.56e-05	0.00281	CbGpPWpGaD
Metronidazole—Dizziness—Topiramate—epilepsy syndrome	2.55e-05	8.52e-05	CcSEcCtD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.54e-05	0.00279	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	2.46e-05	0.0027	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	2.46e-05	0.0027	CbGpPWpGaD
Metronidazole—Vomiting—Topiramate—epilepsy syndrome	2.45e-05	8.19e-05	CcSEcCtD
Metronidazole—CYP2C8—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.44e-05	0.00268	CbGpPWpGaD
Metronidazole—Rash—Topiramate—epilepsy syndrome	2.43e-05	8.13e-05	CcSEcCtD
Metronidazole—Dermatitis—Topiramate—epilepsy syndrome	2.43e-05	8.12e-05	CcSEcCtD
Metronidazole—Headache—Topiramate—epilepsy syndrome	2.42e-05	8.07e-05	CcSEcCtD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.35e-05	0.00258	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP2D6—epilepsy syndrome	2.33e-05	0.00255	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.29e-05	0.00252	CbGpPWpGaD
Metronidazole—Nausea—Topiramate—epilepsy syndrome	2.29e-05	7.65e-05	CcSEcCtD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.29e-05	0.00251	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.15e-05	0.00236	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.14e-05	0.00236	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	2.11e-05	0.00232	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	2.1e-05	0.0023	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.09e-05	0.0023	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.08e-05	0.00229	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.07e-05	0.00227	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.01e-05	0.00221	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	1.99e-05	0.00218	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	1.89e-05	0.00208	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.87e-05	0.00205	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	1.86e-05	0.00204	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.83e-05	0.00201	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CA13—epilepsy syndrome	1.77e-05	0.00195	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.75e-05	0.00192	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	1.7e-05	0.00187	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	1.64e-05	0.0018	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.49e-05	0.00163	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CA13—epilepsy syndrome	1.44e-05	0.00159	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.43e-05	0.00157	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.42e-05	0.00156	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.39e-05	0.00153	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.38e-05	0.00152	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.37e-05	0.00151	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.36e-05	0.0015	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PDXK—epilepsy syndrome	1.34e-05	0.00148	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CERS1—epilepsy syndrome	1.34e-05	0.00148	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—FAR1—epilepsy syndrome	1.34e-05	0.00148	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GLUD1—epilepsy syndrome	1.34e-05	0.00148	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—L2HGDH—epilepsy syndrome	1.34e-05	0.00148	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ADK—epilepsy syndrome	1.34e-05	0.00148	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.25e-05	0.00137	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.23e-05	0.00135	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GAMT—epilepsy syndrome	1.23e-05	0.00135	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PNPO—epilepsy syndrome	1.23e-05	0.00135	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—EPM2A—epilepsy syndrome	1.23e-05	0.00135	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NHLRC1—epilepsy syndrome	1.23e-05	0.00135	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.16e-05	0.00128	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.15e-05	0.00126	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—QDPR—epilepsy syndrome	1.14e-05	0.00126	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CA4—epilepsy syndrome	1.14e-05	0.00126	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—POMC—epilepsy syndrome	1.14e-05	0.00125	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.09e-05	0.0012	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.09e-05	0.0012	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.09e-05	0.0012	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.09e-05	0.0012	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.09e-05	0.0012	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.09e-05	0.0012	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—COX3—epilepsy syndrome	1.07e-05	0.00118	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CACNA2D2—epilepsy syndrome	1.02e-05	0.00112	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SLC6A8—epilepsy syndrome	1.02e-05	0.00112	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—KCNB1—epilepsy syndrome	1.02e-05	0.00112	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SLCO1A2—epilepsy syndrome	1.02e-05	0.00112	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PFKL—epilepsy syndrome	1.02e-05	0.00112	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1e-05	0.0011	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1e-05	0.0011	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1e-05	0.0011	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1e-05	0.0011	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.95e-06	0.00109	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.89e-06	0.00109	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CA13—epilepsy syndrome	9.52e-06	0.00105	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ATIC—epilepsy syndrome	9.32e-06	0.00102	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—UPB1—epilepsy syndrome	9.32e-06	0.00102	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NEU1—epilepsy syndrome	9.32e-06	0.00102	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CA4—epilepsy syndrome	9.3e-06	0.00102	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—QDPR—epilepsy syndrome	9.3e-06	0.00102	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	9.27e-06	0.00102	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	8.97e-06	0.000985	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—COX3—epilepsy syndrome	8.74e-06	0.00096	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GBE1—epilepsy syndrome	8.66e-06	0.000951	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	8.66e-06	0.000951	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.46e-06	0.00093	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	8.29e-06	0.00091	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	8.29e-06	0.00091	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	8.29e-06	0.00091	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PFKL—epilepsy syndrome	8.29e-06	0.00091	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	8.29e-06	0.00091	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	8.14e-06	0.000894	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.1e-06	0.00089	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.05e-06	0.000884	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	7.92e-06	0.00087	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NT5E—epilepsy syndrome	7.72e-06	0.000848	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALAD—epilepsy syndrome	7.72e-06	0.000848	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—UPB1—epilepsy syndrome	7.58e-06	0.000833	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ATIC—epilepsy syndrome	7.58e-06	0.000833	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NEU1—epilepsy syndrome	7.58e-06	0.000833	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	7.36e-06	0.000809	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	7.36e-06	0.000809	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	7.3e-06	0.000802	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CERS1—epilepsy syndrome	7.21e-06	0.000792	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PDXK—epilepsy syndrome	7.21e-06	0.000792	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—FAR1—epilepsy syndrome	7.21e-06	0.000792	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ADK—epilepsy syndrome	7.21e-06	0.000792	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	7.21e-06	0.000792	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	7.21e-06	0.000792	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	7.21e-06	0.000792	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ADSL—epilepsy syndrome	7.06e-06	0.000775	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GBE1—epilepsy syndrome	7.05e-06	0.000774	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	7.05e-06	0.000774	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GLUL—epilepsy syndrome	6.92e-06	0.00076	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.89e-06	0.000757	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	6.8e-06	0.000746	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	6.63e-06	0.000728	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PNPO—epilepsy syndrome	6.6e-06	0.000725	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	6.6e-06	0.000725	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	6.6e-06	0.000725	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GAMT—epilepsy syndrome	6.6e-06	0.000725	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	6.45e-06	0.000708	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	6.36e-06	0.000698	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NT5E—epilepsy syndrome	6.28e-06	0.00069	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALAD—epilepsy syndrome	6.28e-06	0.00069	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AQP1—epilepsy syndrome	6.17e-06	0.000678	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.13e-06	0.000674	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.13e-06	0.000674	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.11e-06	0.000672	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	5.99e-06	0.000658	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	5.99e-06	0.000658	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.93e-06	0.000651	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	5.86e-06	0.000644	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.77e-06	0.000633	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ADSL—epilepsy syndrome	5.75e-06	0.000631	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GLUL—epilepsy syndrome	5.63e-06	0.000619	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	5.58e-06	0.000613	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	5.58e-06	0.000613	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	5.53e-06	0.000608	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.47e-06	0.0006	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.47e-06	0.0006	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.47e-06	0.0006	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.47e-06	0.0006	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.47e-06	0.0006	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.2e-06	0.000571	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.17e-06	0.000568	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.09e-06	0.000559	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.02e-06	0.000552	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5e-06	0.000549	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5e-06	0.000549	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5e-06	0.000549	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.82e-06	0.00053	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.81e-06	0.000529	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.65e-06	0.000511	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.65e-06	0.000511	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	4.55e-06	0.0005	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.54e-06	0.000499	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.54e-06	0.000499	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	4.43e-06	0.000487	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	4.41e-06	0.000484	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.37e-06	0.00048	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.37e-06	0.00048	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.25e-06	0.000467	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.23e-06	0.000465	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.14e-06	0.000455	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.14e-06	0.000455	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.14e-06	0.000455	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.99e-06	0.000438	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.98e-06	0.000437	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.95e-06	0.000434	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.95e-06	0.000434	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.87e-06	0.000425	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.79e-06	0.000416	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.79e-06	0.000416	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.77e-06	0.000414	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.72e-06	0.000408	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.7e-06	0.000407	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.65e-06	0.000401	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.61e-06	0.000396	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.6e-06	0.000395	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.59e-06	0.000394	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.56e-06	0.000391	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.56e-06	0.000391	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—TH—epilepsy syndrome	3.54e-06	0.000389	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.49e-06	0.000383	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.41e-06	0.000375	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.31e-06	0.000364	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.25e-06	0.000357	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.24e-06	0.000355	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.08e-06	0.000338	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.07e-06	0.000337	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3e-06	0.000329	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3e-06	0.000329	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.96e-06	0.000325	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.93e-06	0.000321	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.92e-06	0.000321	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.89e-06	0.000318	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—TH—epilepsy syndrome	2.88e-06	0.000317	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.84e-06	0.000312	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.84e-06	0.000312	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.64e-06	0.00029	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.44e-06	0.000268	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.41e-06	0.000264	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.38e-06	0.000261	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.38e-06	0.000261	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.36e-06	0.00026	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.31e-06	0.000254	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.31e-06	0.000254	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.27e-06	0.000249	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.15e-06	0.000236	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.13e-06	0.000234	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.03e-06	0.000223	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.02e-06	0.000222	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.95e-06	0.000214	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.93e-06	0.000212	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.91e-06	0.00021	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—TH—epilepsy syndrome	1.9e-06	0.000209	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.88e-06	0.000207	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.85e-06	0.000203	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.78e-06	0.000195	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.59e-06	0.000174	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.59e-06	0.000174	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.57e-06	0.000172	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	0.000171	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.52e-06	0.000167	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.45e-06	0.000159	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.42e-06	0.000156	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.26e-06	0.000139	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.24e-06	0.000136	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.22e-06	0.000134	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.05e-06	0.000115	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.53e-07	0.000105	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.34e-07	9.16e-05	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKT1—epilepsy syndrome	7.81e-07	8.58e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.36e-07	6.98e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.19e-07	4.6e-05	CbGpPWpGaD
